Aerolyn Biotech is a technology-driven company that has established a tripartite development strategy through proprietary R&D: "core raw material development - industrial technology empowerment - frontier field exploration". Leveraging its expertise in chemistry and enzymatic technologies, the company has developed innovative processes for APIs and cosmetic raw materials, achieving commercial-scale production. It also integrates resources to build differentiated CDMO/CRO services for pharmaceutical and Cosmetic RMs, aiming to help clients achieve commercialization rapidly and cost-effectively.
AeroLyn base in Shanghai while the company operates CRO/CDMO R&D Labs in Hangzhou , with production bases situated in Jiangxi and Shandong Provinces.
